GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Iran Daru (XTEH:IRDR1) » Definitions » Price-to-Free-Cash-Flow

Iran Daru (XTEH:IRDR1) Price-to-Free-Cash-Flow : (As of Jun. 14, 2024)


View and export this data going back to 1990. Start your Free Trial

What is Iran Daru Price-to-Free-Cash-Flow?

As of today (2024-06-14), Iran Daru's share price is IRR12710.00. Iran Daru does not have enough years/quarters to calculate the Free Cash Flow per Share for the trailing twelve months (TTM) ended in . 20. Therefore GuruFocus does not calculate Price-to-Free-Cash-Flow Ratio at this moment.

The historical rank and industry rank for Iran Daru's Price-to-Free-Cash-Flow or its related term are showing as below:

XTEH:IRDR1's Price-to-Free-Cash-Flow is not ranked *
in the Drug Manufacturers industry.
Industry Median: 22.66
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Iran Daru's Free Cash Flow per Share for the six months ended in . 20 was IRR0.00.


Iran Daru Price-to-Free-Cash-Flow Historical Data

The historical data trend for Iran Daru's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Iran Daru Price-to-Free-Cash-Flow Chart

Iran Daru Annual Data
Trend
Price-to-Free-Cash-Flow

Iran Daru Semi-Annual Data
Price-to-Free-Cash-Flow

Competitive Comparison of Iran Daru's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Iran Daru's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Iran Daru's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Iran Daru's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Iran Daru's Price-to-Free-Cash-Flow falls into.



Iran Daru Price-to-Free-Cash-Flow Calculation

Iran Daru's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=12710.00/
=

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Iran Daru  (XTEH:IRDR1) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Iran Daru Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Iran Daru's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Iran Daru (XTEH:IRDR1) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Ayatollah Saeedi Highway, End Of Kermani Street, Moallem Boulevard, Tehran, IRN, 1371658111
Iran Daru is a pharmaceutical company based in Iran. It manufactures and sells pharmaceutical products for antibiotics, cardiovascular agents, and local anesthetic agents. The company manufactures products in three main dosage form categories namely solid, semi-solid, and liquid including tablets, capsules, pellets, sachets, gels, creams, ointments (sterile and non-sterile), spray solutions, and syrups. Products offered by Iran Daru include Diclofenac Potassium, Biotin 5 mg, Tetracycline, Folic acid, Meloxicam, Acetaminophen and Caffeine, and Levocetirizine dihydrochloride, among others. It also exports its products to other countries.

Iran Daru (XTEH:IRDR1) Headlines

No Headlines